New York State officials being lobbied to embrace Opvee, a Narcan alternative
The state health department says the new option, Opvee, hasn't yet been tested enough to promote its widespread use.
Source: newsday.com
📰 Assal Hellmer News
Assal Hellmer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Assal Hellmer. Real-time updates on events, politics, business and more.
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
Assal Hellmer Richards Lindahl Joe Papa Exchange Commission Emergent Biosolutions Inc Apple Podcasts
Source: eagletribune.com
Emergent BioSolutions Releases New Survey Findings
Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment...
Source: globenewswire.com
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
Proactive changes aim to ensure long-term sustainability and growth, optimize operations, streamline processes, and allocate resources more efficientlyReorganization will align with evolving business...
Source: marketscreener.com
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case of an...
United States Joe Papa Richards Lindahl Assal Hellmer Emergent Biosolutions Inc Us Department Of Education
Source: marketscreener.com
Emergent BioSolutions Reports First Quarter 2024 Financial
First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of...
Source: globenewswire.com
Emergent BioSolutions Reports First Quarter 2024 Financial Results
First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 millionUpdates FY 2024 guidance ...
Source: marketscreener.com
Emergent BioSolutions Announces Amendment to its Existing
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and...
Richards Lindahl Joe Papa Assal Hellmer Exchange Commission Emergent Biosolutions Inc Apple Podcasts
Source: globenewswire.com
Emergent BioSolutions to Release First Quarter 2024 Financial Results and Conduct Conference Call on May 1, 2024
GAITHERSBURG - Emergent BioSolutions Inc. will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first quarter 2024, key business...
Source: marketscreener.com
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
GAITHERSBURG, Md., April 22, 2024 -- Emergent BioSolutions Inc. will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first...
Source: marketscreener.com